What is patient readiness in clinical trials?
Patient readiness refers to whether individuals are prepared cognitively, emotionally, logistically, and contextually to start, persist in, and complete a clinical trial. It reflects real-world capacity to participate, not just protocol fit. Readiness is the variable between eligibility and completion that most trial models fail to measure or develop.
How is readiness different from eligibility?
Eligibility determines who can enroll in a trial based on inclusion/exclusion criteria. Readiness determines who will remain engaged and complete it based on cognitive, behavioral, structural, and contextual factors. Trials optimized for eligibility alone experience preventable screen failure and dropout.
Why does readiness matter for trial outcomes?
Readiness directly influences enrollment quality, retention durability, site burden, rescue recruitment, and completion rates. Trials designed around readiness behave more predictably than those designed around volume because they address the behavioral and contextual factors that determine whether patients finish.
What is The Readiness System?
The Readiness System is Jumo Health's integrated media framework for examining clinical trial execution. It includes The Readiness Gap, From Consent to Commitment, and Readiness Brief. Together they diagnose execution failure, explore the human decisions behind it, and distill actionable signals for trial leaders.
What is The Readiness Gap blog?
The Readiness Gap is Jumo Health's blog exploring the disconnect between eligibility and execution in clinical trials. It examines why screen failure, dropout, and site overload are predictable symptoms of readiness failure, drawing on behavioral science, trial data, and frontline operator insight. Published weekly.
What is the From Consent to Commitment podcast?
From Consent to Commitment is Jumo Health's long-form conversation series featuring sponsors, CRO leaders, site operators, patient advocates, and behavioral scientists. Each episode examines where patients disengage before dropout shows in the data and what turns consent into sustained commitment. Published biweekly.
What is the Readiness Brief newsletter?
Readiness Brief is a concise, executive-level newsletter for leaders accountable for trial outcomes. Each edition surfaces a single high-signal insight: a trend, data point, or execution lesson that reveals how readiness shapes enrollment quality, retention, and completion risk. Designed to be read quickly and acted on immediately.
What is Jumo Health's role in readiness?
Jumo Health is a Patient Experience Organization founded in 2009. It develops content, systems, and operating models focused on improving patient readiness and clinical trial execution. Its two products, CORE and PRISM, operationalize readiness across the full trial lifecycle.
Is this content independent of Jumo's products?
Yes. While informed by Jumo's experience across sponsors, CROs, sites, and patient communities, the ideas and frameworks shared on this page are intended to advance industry understanding of readiness and execution regardless of vendor or solution. The Readiness System is a knowledge resource, not a product pitch.
How do I subscribe to Readiness Brief?
Enter your email address in the subscription form on this page. Readiness Brief is delivered periodically and contains one high-signal insight per edition. No spam. No product pitches. Just what matters for delivering trials on plan.
